2017 Catecholamines Gordon Research Conference & Gordon Research Seminar

摘要 2017年戈登儿茶酚胺研究会议将在密苏里州纽里市的周日河举行 2017年8月。这个每隔一年举行一次的小型会议是探索新发展的理想论坛。 在儿茶酚胺领域。这也是初级调查人员和受训人员互动的绝佳机会 在轻松的气氛中与老牌调查人员在一起。对最近会议的评价突出了 这次会议通常对新兴和老牌科学家都有很大的影响。随着资金的分配 由于戈登会议组织的资金有限，我们正在申请其他来源的资金。我们是 希望我们的请求结果使我们能够支持演讲者和讨论领导者以及初级 调查人员参加会议。会议包括Marina Wolf博士和Marina Wolf博士的两次全体会议 艾米·阿恩斯滕医生。初步计划包括一大批初级科学家和女性， 计划的课程包括：1)药物滥用，2)神经生理学和神经传递，3) 神经退化，4)认知，5)压力/情感障碍，6)电路和分子，以及7)学习和 动力。关于儿茶酚胺的2017年戈登会议所涵盖的主题与 了解药物成瘾的神经生物学基础以及与衰老和 神经精神障碍。本次论坛将提供一个独特的机会来讨论 了解儿茶酚胺系统如何在这些疾病的病理生理和治疗中起作用 条件。很大比例的参与者是初级调查员和相当多的人 将对研究生和博士后保证，这次会议可能会对未来产生怎样的影响 几代神经学家都在关注这些问题。

Summary The 2017 Gordon Research Conference on Catecholamines will take place at Sunday River in Newry, ME in August 2017. This small conference, held every other year, is an ideal forum for exploring new developments in the field of catecholamines. It is also an excellent opportunity for junior investigators and trainees to interact with established investigators in a relaxed atmosphere. The evaluations of recent conferences highlight the strong impact this meeting typically has on emerging as well as established scientists. As the funds allocated by the Gordon Conference organization are limited, we are requesting funding from other sources. We are hoping that the results of our requests enable us to support speakers and discussion leaders as well as junior investigators to participate in the meeting. The conference includes two plenary talks, by Dr. Marina Wolf and Dr. Amy Arnsten. The preliminary program includes a large number of junior scientists and women, and the sessions planned include: 1) Substance Abuse, 2) Neurophysiology and Neurotransmission, 3) Neurodegeneration, 4) Cognition, 5) Stress/Affective Disorders, 6) Circuits and Molecules, and 7) Learning and Motivation. The themes covered in the 2017 Gordon Conference on Catecholamines are highly relevant to understanding the neurobiological bases of drug addiction as well as neurological diseases of aging and neuropsychiatric disorders. This forum will provide a unique opportunity to discuss recent advances in the understanding of how catecholamine systems may contribute to the pathophysiology and treatment of those conditions. The fact that a large proportion of the participants are junior investigators and a significant number will be graduate students and postdocs ensure that this conference may have an impact on how future generations of neuroscientists view these issues.